Search research articles
Contact Us
Filters
Showing results (41-50 of 88) with videos related to
Page
of 9
Sort By:
International Journal of Pharmaceutics
|
June 19, 2017
Surface engineering of Solid Lipid Nanoparticle assemblies by methyl α-d-mannopyranoside for the active targeting to macrophages in anti-tuberculosis inhalation therapy
Eleonora Maretti, Luca Costantino, Cecilia Rustichelli, et al.
International Journal of Pharmaceutics
|
July 31, 2016
Solid Lipid Nanoparticle assemblies (SLNas) for an anti-TB inhalation treatment-A Design of Experiments approach to investigate the influence of pre-freezing conditions on the powder respirability
Eleonora Maretti, Cecilia Rustichelli, Marcello Romagnoli, et al.
International Journal of Pharmaceutics
|
October 18, 2011
Layered lipid microcapsules for mesalazine delayed-release in children
Anna Giulia Balducci, Gaia Colombo, Giuseppe Corace, et al.
Pharmaceutical Research
|
November 18, 2015
Multivariate Analysis of Effects of Asthmatic Patient Respiratory Profiles on the In Vitro Performance of a Reservoir Multidose and a Capsule-Based Dry Powder Inhaler
Francesca Buttini, Irene Pasquali, Gaetano Brambilla, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society
|
February 23, 2013
Lecithin/chitosan controlled release nanopreparations of tamoxifen citrate: loading, enzyme-trigger release and cell uptake
Stefano Barbieri, Fabio Sonvico, Caterina Como, et al.
Pharmaceutics
|
June 26, 2026
CaP-Coated Cyclosporine A Liposomes Formulated as an Inhalable Dry Powder for Lung Inflammatory Diseases
Davide D'Angelo, Stefania Glieca, Lisa Flammini, et al.
Drug Development and Industrial Pharmacy
|
August 8, 2019
Dry powder inhaler of colistimethate sodium for lung infections in cystic fibrosis: optimization of powder construction
Jana Kozáková, Ayça Altay, Vladimír Ždímal, et al.
International Journal of Pharmaceutics
|
February 9, 2016
Combinations of colistin solutions and nebulisers for lung infection management in cystic fibrosis patients
Francesca Buttini, Irene Rossi, Marica Di Cuia, et al.
International Journal of Pharmaceutics
|
February 5, 2014
Differences in physical chemistry and dissolution rate of solid particle aerosols from solution pressurised inhalers
Francesca Buttini, Michele Miozzi, Anna Giulia Balducci, et al.
Pharmaceutics
|
March 16, 2018
Surface-Modified Nanocarriers for Nose-to-Brain Delivery: From Bioadhesion to Targeting
Fabio Sonvico, Adryana Clementino, Francesca Buttini, et al.
Page
of 9
Search research articles
Search
Showing results (41-50 of 88) with videos related to
Sort By:
Page
of 9
International Journal of Pharmaceutics
|
June 19, 2017
Surface engineering of Solid Lipid Nanoparticle assemblies by methyl α-d-mannopyranoside for the active targeting to macrophages in anti-tuberculosis inhalation therapy
Eleonora Maretti, Luca Costantino, Cecilia Rustichelli, et al.
International Journal of Pharmaceutics
|
July 31, 2016
Solid Lipid Nanoparticle assemblies (SLNas) for an anti-TB inhalation treatment-A Design of Experiments approach to investigate the influence of pre-freezing conditions on the powder respirability
Eleonora Maretti, Cecilia Rustichelli, Marcello Romagnoli, et al.
International Journal of Pharmaceutics
|
October 18, 2011
Layered lipid microcapsules for mesalazine delayed-release in children
Anna Giulia Balducci, Gaia Colombo, Giuseppe Corace, et al.
Pharmaceutical Research
|
November 18, 2015
Multivariate Analysis of Effects of Asthmatic Patient Respiratory Profiles on the In Vitro Performance of a Reservoir Multidose and a Capsule-Based Dry Powder Inhaler
Francesca Buttini, Irene Pasquali, Gaetano Brambilla, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society
|
February 23, 2013
Lecithin/chitosan controlled release nanopreparations of tamoxifen citrate: loading, enzyme-trigger release and cell uptake
Stefano Barbieri, Fabio Sonvico, Caterina Como, et al.
Pharmaceutics
|
June 26, 2026
CaP-Coated Cyclosporine A Liposomes Formulated as an Inhalable Dry Powder for Lung Inflammatory Diseases
Davide D'Angelo, Stefania Glieca, Lisa Flammini, et al.
Drug Development and Industrial Pharmacy
|
August 8, 2019
Dry powder inhaler of colistimethate sodium for lung infections in cystic fibrosis: optimization of powder construction
Jana Kozáková, Ayça Altay, Vladimír Ždímal, et al.
International Journal of Pharmaceutics
|
February 9, 2016
Combinations of colistin solutions and nebulisers for lung infection management in cystic fibrosis patients
Francesca Buttini, Irene Rossi, Marica Di Cuia, et al.
International Journal of Pharmaceutics
|
February 5, 2014
Differences in physical chemistry and dissolution rate of solid particle aerosols from solution pressurised inhalers
Francesca Buttini, Michele Miozzi, Anna Giulia Balducci, et al.
Pharmaceutics
|
March 16, 2018
Surface-Modified Nanocarriers for Nose-to-Brain Delivery: From Bioadhesion to Targeting
Fabio Sonvico, Adryana Clementino, Francesca Buttini, et al.
Page
of 9